Search
news › boeynaems-awarded-cprit-grant-to-study-stress-response-in-cells
… our cells are not completely defenseless. Nature has evolved innovative mechanisms for organisms to protect …
research › ... › managing-multiple-mission-plans
… turned into a mission plan. Remember, a good mission plan has multiple steps spanning the anxiety scale to reach a … you or your child from continuing to work through each phase of your mission plans. Sometimes when challenging …
news › the-importance-of-sleep-during-the-teen-years
… for high schoolers. “A good sleep schedule is one that has good quality, quantity and consistency,” said Dr. Sonal …
news › bcm-receives-3-5-million-to-study-telehealth-genetic-services-for-sick-underserved-newborns
… necessary to provide this care. Baylor College of Medicine has received a $3.5 million from the National Human Genome …
news › commuters-guide-for-braving-the-heat
… Not everyone has parking close to their place of employment – many people …
news › how-estrogens-millisecond-fast-action-happens
… protein-1, can physically interact with ER-alpha. Clic1has been implicated in the regulation of neuronal …
news › dr-graham-erwin-receives-nih-new-innovator-award
… molecular and human genetics at Baylor College of Medicine, has been awarded the National Institutes of Health … of the impacted gene. An analog of that molecule is now in Phase 1 clinical trials for patients with Friedreich ataxia. …
news › researchers-show-benefit-of-ultra-deep-rna-sequencing-in-mendelian-disorder-diagnostics
… but the optimized sequencing depth for this technology has not yet been determined. In a new study published in the …
news › zr-fusion-protein-sways-normal-brain-cell-development-toward-cancer-growth
… on cancer-promoting genes. However, a longstanding mystery has been why this fusion protein only causes tumors during …
news › dan-l-duncan-comprehensive-cancer-center-to-open-cell-therapy-clinical-trials-at-harris-health
… The pilot program at Harris Health will begin with phase I and II cell therapy clinical trials currently open at … Gene Therapy to treat multiple myeloma. “This first trial has minimal risk and will apply to the most patients,” said …